TNYA - Tenaya Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

373.2M

Cash

147.8M

Avg Qtr Burn

-26.49M

Short % of Float

4.55%

Insider Ownership

4.06%

Institutional Own.

87.82%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
TN-201 Details Hypertrophic cardiomyopathies	Phase 1b Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TN-301 Details Heart failure	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.